Click here to view next page of this article

 

Medical Library. Full Text Journals Medical Books Online. Physicians Drug Reference

Vaccines -- Vanadium van Buchem's disease -- Vascular diseases Vascular endothelial growth factor -- Ventilation disorders Ventilation-perfusion lung scans -- Verruga peruana Vertebral fractures, back pain from -- Vindesine, for melanoma -- Vinorelbine, for cancer -- Vitamin A Vitamin B -- Vitamin K Vitamin K antagonists -- VZV

Vaccines [ch122] [ch10 ¶20]

[see also: Immunization and individual vaccines]

access to [ch122 ¶58-¶62] [ch122 Table11] [ch122 Table12]

administration [ch122 ¶34-¶36]

anamnestic response [ch122 ¶14]

for breast feeding women [ch122 ¶48]

in cancer patients [ch87 ¶57-¶58]

and cancer prevention [ch82 ¶29]

Children's Vaccine Initiative [ch122 ¶68] [ch122 Table15]

constituents [ch122 Table3]

contraindications and precautions [ch122 Table6]

control of vaccine-preventable diseases [ch122 ¶66-¶67] [ch122 Table12] [ch122 Table13]

definitions [ch122 ¶4] [ch122 Table2]

delivery of [ch122 Figure1] [ch122 ¶56-¶57] [ch122 Table1] [ch122 Table15]

development of [ch122 ¶23-¶36]

biologic impediments [ch122 ¶23]

strategy for [ch122 ¶24-¶26]

development of new [ch122 ¶71] [ch122 Table16]

erythema multiforme from [ch57 ¶52]

formulations [ch122 ¶27-¶31]

for health care workers [ch122 ¶34-¶36]

for the HIV infected [ch122 ¶50]

hypersensitivity reactions [ch122 ¶15]

for immunocompromised hosts [ch122 ¶50-¶51] [ch122 Table8] [ch136 Table5]

for infants and children [ch122 Figure2] [ch122 ¶41] [ch122 Table4]

levels of [ch122 Table11]

international considerations [ch122 ¶72-¶74]

live [ch122 ¶28-¶30]

National Vaccine Injury Compensation program [ch122 ¶65]

new diseases [ch122 ¶70]

for occupational exposures [ch122 ¶49]

postexposure [ch122 ¶52] [ch122 Table9]

in pregnancy [ch122 ¶47]

primary failure [ch122 ¶13]

primary response [ch122 ¶13]

production of [ch122 ¶32-¶33]

race/ethnicity and [ch4 Table6]

recording and reporting requirements [ch122 ¶39]

reemergence of controlled disease [ch122 ¶70]

research [ch122 ¶68-¶71] [ch122 Table16]

for HIV [ch308 ¶315-¶318]

for routine use [ch122 ¶41-¶46]

in adults [ch122 ¶42-¶43]

adverse events [ch122 ¶44-¶46] [ch122 Table6] [ch122 Table7]

in infants and children [ch122 Figure2] [ch122 ¶41] [ch122 Table4]

secondary failure [ch122 ¶14]

secondary response [ch122 ¶14]

simultaneous administration of multiple [ch122 ¶53-¶54]

for transplant recipients [ch136 ¶49-¶52] [ch136 Table5] [ch136 Table5]

for travelers [ch122 ¶55] [ch123 ¶7-¶12]

tumor [ch86 ¶138]

use of [ch122 ¶37-¶65] [ch122 Table4] [ch122 Table5]

Vaccinia [ch188 ¶4-¶5]

Vaccinia immune globulin [ch122 Table9] [ch188 ¶5]

Vagina

bleeding [ch52 ¶4]

congenital absence [ch339 ¶63-¶66]

disorders [ch337 ¶142-¶143]

Vaginal carcinoma, drug-induced [ch69 Table1]

Vaginal pain [ch52 ¶20]

Vaginal trichomoniasis [ch129 ¶25-¶27] [ch337 ¶142]

Vaginitis

anaerobic

 

[see: Vaginosis, bacterial]

atrophic, and incontinence [ch9 ¶37]

nonspecific

 

[see: Vaginosis, bacterial]

Vaginosis, bacterial [ch129 ¶24] [ch129 ¶28-¶37] [ch129 Table3]

diagnosis [ch129 Figure1] [ch129 ¶30] [ch129 Table3]

treatment [ch129 ¶36]

Vagotomy, for peptic ulcers [ch284 ¶98-¶100] [ch284 Table3]

Vagus nerve

disorders [ch372 ¶33-¶37]

and taste [ch29 ¶22]

Valacyclovir [ch183 ¶22]

for HSV [ch184 ¶41] [ch184 ¶42-¶43] [ch184 Table1] [ch308 ¶202]

for VZV [ch183 Table1] [ch185 ¶28]

Valine, inherited catabolic disorders [ch349 Table1]

Valproate/valproic acid

adverse effects [ch385 Table10]

for bipolar disorders [ch385 ¶71]

dosages [ch385 Table10]

fatty liver from [ch300 ¶11]

for migraine [ch364 ¶21-¶22]

Valsalva maneuver [ch371 ¶14-¶15] [ch371 Table3]

Valvular heart disease [ch237]

[see also: individual valves]

aortic regurgitation [ch237 ¶95-¶121]

aortic stenosis [ch237 ¶59-¶93]

mitral regurgitation [ch237 ¶33-¶50]

mitral stenosis [ch237 ¶2-¶32]

mitral valve prolapse [ch237 ¶51-¶58]

in pregnancy [ch7 ¶17]

pulmonic valve disease [ch237 ¶134]

replacement of valves for [ch237 ¶132-¶133]

rheumatic fever [ch236 ¶11]

and endocarditis [ch126 ¶13]

tricuspid regurgitation [ch237 ¶129-¶133]

tricuspid stenosis [ch237 ¶122-¶128]

Vanadium [ch80 ¶20]

and lung disease [ch254 Table1]

 

V *Vaccines -- Vanadium van Buchem's disease -- Vascular diseases Vascular endothelial growth factor -- Ventilation disorders Ventilation-perfusion lung scans -- Verruga peruana Vertebral fractures, back pain from -- Vindesine, for melanoma -- Vinorelbine, for cancer -- Vitamin A Vitamin B -- Vitamin K Vitamin K antagonists -- VZV

Vaccinia

Vaginismus

Vaginitis

Vaginosis

Varicella Zoster Virus

Varicose Veins

Varicose Veins and Spider Veins

Variegate Porphyria

Venous Lakes

Venous Insufficiency

Venous Lakes

Venous Lakes

Venous Insufficiency

Ventricular Septal Defect

Ventricular Premature Complexes

Ventricular Fibrillation

Ventricular Tachycardia

Ventricular Rupture

Verrucous Carcinoma

Vertebral Artery Atherothrombosis

Vesiculoureteral Reflux

Vesiculovirus

Vibrio Infections

Vincent's Infection

Vincent's Angina

VIPomas

Visceral Venous Thrombosis

Vitamin K Deficiency

Vitamin E Deficiency

Vitamin E Toxicity

Vitamin K Toxicity

Vitamin A Deficiency

Vitavim A Toxicity

Vitiligo

Von Willibrand's Disease

Vulvovaginitis